BR112012026198A2 - comprimidos efervescentes compreendendo um componente oleoso - Google Patents

comprimidos efervescentes compreendendo um componente oleoso

Info

Publication number
BR112012026198A2
BR112012026198A2 BR112012026198A BR112012026198A BR112012026198A2 BR 112012026198 A2 BR112012026198 A2 BR 112012026198A2 BR 112012026198 A BR112012026198 A BR 112012026198A BR 112012026198 A BR112012026198 A BR 112012026198A BR 112012026198 A2 BR112012026198 A2 BR 112012026198A2
Authority
BR
Brazil
Prior art keywords
oily component
oil
effervescent
effervescent tablets
water
Prior art date
Application number
BR112012026198A
Other languages
English (en)
Inventor
David Michael
Kyle M Johnson
Laknath Anslem Goonetilleke
Original Assignee
Amerilab Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amerilab Technologies Inc filed Critical Amerilab Technologies Inc
Publication of BR112012026198A2 publication Critical patent/BR112012026198A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Abstract

comprimidos efervescentes compreendendo um componente oleoso. comprimido efervescente que inclui cerca de 20% a cerca de 80% em peso de agente efervescente incluindo um ácido e uma base, opcionalmente cerca de 2% a cerca de 20% em peso de um compoenente que é insolúvel em água, ligeiramente solúvel em água ou moderadamente solúvel em água (por exemplo, aspartamente, cerca de 5% em peso a cerca de 25% em peso de um primeiro algutinante e pelo menos 0,1% em peso do componente oleoso que inclui pelo menos um ácido graxo compreendendo uma cadeia alquila apresentando pelo menos 10 átomos de carbono, óleo de açafrão, óleo de girassol, óleo de semente de linho e óleo de gérmen de trigo, o comprimido apresentando uma dureza de pelo menos 2 kilogramas.
BR112012026198A 2010-04-13 2011-04-13 comprimidos efervescentes compreendendo um componente oleoso BR112012026198A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32360310P 2010-04-13 2010-04-13
PCT/US2011/032363 WO2011130440A1 (en) 2010-04-13 2011-04-13 Effervescent tablets comprising an oil component
US13/086,298 US20110281008A1 (en) 2010-04-13 2011-04-13 Effervescent tablet with improved dissolution time and method of using the same

Publications (1)

Publication Number Publication Date
BR112012026198A2 true BR112012026198A2 (pt) 2016-07-05

Family

ID=44259675

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012026198A BR112012026198A2 (pt) 2010-04-13 2011-04-13 comprimidos efervescentes compreendendo um componente oleoso

Country Status (4)

Country Link
US (1) US20110281008A1 (pt)
EP (1) EP2558066A1 (pt)
BR (1) BR112012026198A2 (pt)
WO (1) WO2011130440A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2863613C (en) 2012-02-01 2020-10-27 Intercontinental Great Brands Llc Low calorie drink tablet
WO2013165327A1 (en) * 2012-04-30 2013-11-07 Mahmut Bilgic Pharmaceutical formulations comprising thiocolchicoside
CN102687781B (zh) * 2012-05-23 2014-03-05 耿福能 苦荞茶泡腾片及其制备方法
WO2014145285A1 (en) * 2013-03-15 2014-09-18 Mylan Inc. Manufacturing process for effervescent dosage forms
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
US10327468B2 (en) * 2017-10-11 2019-06-25 Sebastian Scholl System and methods for imparting flavor in liquid filtration inhalation apparatuses
EP3886819A1 (en) 2018-11-30 2021-10-06 Amerilab Technologies, Inc. Rapidly disintegrating effervescent tablets and methods of making the same
MX2019013539A (es) * 2019-11-12 2021-05-13 Valenzuela Carlos Roberto Rosado Pastilla efervescente saborizada para preparación de bebidas instantáneas y método de fabricación.
GB2591289B (en) * 2020-01-24 2024-03-27 Moxcha Ltd Beverage composition
CN115624125B (zh) * 2022-10-28 2024-03-08 广州王老吉大健康产业有限公司 一种泡腾片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
EP1490024B1 (en) * 2002-03-06 2012-01-18 EffRx Pharmaceuticals SA Effervescent compositions comprising alendronate
US6811793B2 (en) * 2002-03-11 2004-11-02 Amerilab Technologies, Inc. Effervescent composition including stevia
US7507396B2 (en) * 2003-10-17 2009-03-24 Amerilab Technologies, Inc. Effervescent composition and method of making an effervescent composition including a viscous component
US7815897B1 (en) * 2003-12-22 2010-10-19 Amerilab Technologies, Inc. Therapeutic effervescent composition
US7785640B2 (en) * 2004-01-16 2010-08-31 Amerilab Technologies, Inc. Effervescent composition including cranberry extract
US20060039972A1 (en) * 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including a grape-derived component
WO2007075408A2 (en) * 2005-12-16 2007-07-05 Effrx, Inc. Effervescent compositions for triptans
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
EP2283823B1 (en) * 2009-07-29 2012-07-11 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Effervescent formulations comprising a phosphonate and methods for their preparation

Also Published As

Publication number Publication date
WO2011130440A1 (en) 2011-10-20
US20110281008A1 (en) 2011-11-17
EP2558066A1 (en) 2013-02-20

Similar Documents

Publication Publication Date Title
BR112012026198A2 (pt) comprimidos efervescentes compreendendo um componente oleoso
BR112012017564A2 (pt) Formulação antimicrobiana
BR112015012840A2 (pt) composto, composição, e, uso de um composto ou um sal, solvato, éster ou pró-droga farmaceuticamente aceitável do mesmo
AR054581A1 (es) Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion
CU20130137A7 (es) Derivados de ácido 3- fenilpropiónico ramificados y su uso
GT200900027A (es) Compuestos organicos
EA201291108A1 (ru) Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген
HN2010002786A (es) Compuestoa quimicos 251
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
MY158504A (en) Fatty acid niacin conjugates and their uses
CR9230A (es) Uso de derivados del acido tetramico para el control de los insectos del genero de los hemipteros (sternorrhyncha)
BR112014028673A2 (pt) componente de calçado de malha com uma faixa de calcanhar embutida
BR112012009487A2 (pt) formulações de espessante estáveis
CL2011001712A1 (es) Combinacion de 0,1 a 1 mg de al menos un estimulador de sgc seleccionado de un grupo definido con 2,5 a 20 mg de un inhibidor de pde5 seleccionado de otro grupo; formulacion farmaceutica que la comprende y uso en el tratamiento de la disfuncion sexual masculina.
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BR112012017136A2 (pt) Composição farmacêutica compreendendo 3-beta- hidróxi-5-alfa-pregnan-20-ona com propriedades de armazenamento e solubidade aperfeiçoadas.
BR112015026840A2 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia
CO6341625A2 (es) Derivados de indol como agentes anticáncer
MA33760B1 (fr) Dérivés spirolactames et leurs utilisations
ECSP10010683A (es) Una formulacion farmacéutica sólida
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
UY30424A1 (es) Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos.
BR112015002416A2 (pt) agente de ligação com estabilidade biodegradável para um detergente sólido
BR112013026155A2 (pt) dispositivo para a remoção de pêlos que compreende um tensoativo modificador

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]